Drug Database
ES

estradiol (Vagifem)

✓ Approved

Novo Nordisk A/S · ESR1 · 小分子

什么是 estradiol?

estradiol 是一种小分子,由Novo Nordisk A/S研发。该药已获批,用于治疗相关适应症,给药途径:Intravaginal。

药物档案

商品名Vagifem
公司Novo Nordisk A/S
药物类别小分子
分子靶点ESR1
给药途径Intravaginal
状态Approved

作用机制

分子靶点

estradiol 作用于 1 个分子靶点:

ESR1estrogen receptor 1 (ER, ESR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

estradiol 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Reproductive system and breast disordersAtrophic vulvovaginitis✓ Approved

相关研究文献

PubMedCell communication and signaling : CCS2026-11-17

Design and characterization of a LuxS/AI-2 pathway-informed scorpion venom-derived hybrid peptide IFG-22 for selective inhibition of Gardnerella vaginalis biofilms in bacterial vaginosis.

Xu Wenxin W, Zhang Zhiren Z, Xu Qingbo Q, Wang Dandan D et al.

Bacterial vaginosis (BV) is a common vaginal dysbiosis characterized by Gardnerella vaginalis overgrowth, biofilm persistence, inflammation, and disruption of Lactobacillus-dominated microbiota. Conventional antibiotics such as metronidazole are limited by recurrence, incomplete biofilm clearance, and potential disturbance of beneficial commensals. Here, we designed and characterized IFG-22, a LuxS/AI-2 pathway-informed scorpion venom-derived hybrid antimicrobial peptide, to preferentially target G. vaginalis biofilms while preserving vaginal microbial homeostasis. IFG-22 was generated by integrating a LuxS-guided recognition motif with a membrane-active antimicrobial fragment and was optimized through molecular docking and physicochemical screening. IFG-22 showed potent anti-Gardnerella activity, with a minimum inhibitory concentration of 1.2 µg/mL, rapid bactericidal kinetics, and marked inhibition of biofilm formation and persistence. Mechanistic assays indicated that IFG-22 attenuated AI-2-associated signaling output, showed partially DPD/AI-2-rescuable biofilm suppression, selectively interacted with G. vaginalis biofilm lipid components, and induced bacterial membrane disruption. These findings support a combined mechanism in which membrane disruption drives rapid killing, while AI-2-associated signaling attenuation contributes to anti-biofilm activity. IFG-22 displayed weaker activity against representative vaginal commensals than against G. vaginalis and showed preliminary compatibility with vaginal epithelial cells within the effective antimicrobial concentration range. In a murine BV model, IFG-22 reduced G. vaginalis expansion, promoted restoration toward a Lactobacillus-dominated microbiota, and downregulated inflammatory mediator expression in vaginal tissues. IFG-22 also retained substantial peptide integrity and anti-Gardnerella activity under simulated vaginal microenvironmental conditions. Collectively, IFG-22 represents a promising membrane-active and microbiota-sparing peptide candidate for local BV therapy.

PMID 43040356
阅读全文 →
PubMedNature communications2026-11-17

Rapid assessment of chemical complementarity of ligands for protein design.

Petrenas Rokas R, Ożga Katarzyna K, Chubb Joel J JJ, Romanyuk Andrey V AV et al.

Driven by deep-learning methods, computational protein design can now rapidly generate de novo structures, opening new frontiers for creating proteins that bind small molecules tightly and specifically, although achieving predictable and tunable binding remains challenging. Here we address this with a rapid physics-based computational method to generate isosteric and chemically complementary binding pockets for small-molecule targets in de novo designed proteins. We test this experimentally by constructing and characterizing binding proteins for several synthetic and natural chromophores. By evaluating only single-digit numbers of designs, the pipeline delivers stable proteins with pre-organised binding sites in apo structures confirmed by X-ray crystallography, which bind the targets with micromolar affinities or better. To illustrate the scope and applications of this approach, we incorporate selective and coupled chromophore-binding sites in a two-domain de novo protein enabling controlled energy transfer between the two sites, and we develop a small de novo binding protein that can be used in live mammalian cells to visualise sub-cellular structures.

PMID 43039905
阅读全文 →
PubMedBMC women's health2026-11-17

Effectiveness of vaginal versus oral progesterone therapy in patients with endometrial hyperplasia: a randomized clinical trial.

Tehranian Afsaneh A, Mollaamin Zahra Z, Aghajani Faezeh F, Rastad Hadith H et al.

Progesterone therapy is the main drug for the treatment of endometrial hyperplasia as a precursor of endometrial cancer. Considering the side effects of systemic progesterone use, we decided to compare the effectiveness and side effects of vaginal use versus oral use. This parallel group randomized clinical trial was conducted among 80 women with EH, without atypia, and abnormal uterine bleeding (AUB). Participants were allocated to two groups. Participants in group I received MPA, 2 tablets (5 mg) orally for 14 days per month for 3 months. Participants in group II obtained a 100 mg soft gelatin Progesterone capsule for vaginal use at the same time. 3-4 weeks after the completion of the treatment, the patient's endometrial thicknesses were measured, and endometrial samples were obtained. Finally, 39 and 36 participants were evaluated from groups I and II. The mean endometrial thickness significantly decreased after the intervention compared to before in each group (All p < 0.05), but no statistically significant difference was seen (P = 0.37) between groups. The clinical and histologic effects of vaginal MP are the same as MPA, after three cycles of treatment of EH without atypia. IRCT20140820018866N8. Registered 10/11/2019 Prospectively registered, https//www.irct.ir/trial/41,581.

PMID 43040524
阅读全文 →
PubMedPediatrics international : official journal of the Japan Pediatric Society2026-11-17

Pitfalls of Unusual Anorectal Pathology: Rectovaginal Fistula With Ectopic Vaginal Opening in Anus and Normal Urethra.

Seo Shogo S, Iida Hisae H, Ochi Takanori T, Koga Hiroyuki H et al.

PMID 43040792
阅读全文 →
PubMedRapid communications in mass spectrometry : RCM2026-11-17

EncNovo: De Novo Peptide Sequencing With an Encoder-Only Architectures.

Zhu Xinglong X, Chen Zejiang Z, Huang Zihao Z, Wang Haipeng H

De novo peptide sequencing enables interpretation of tandem mass spectrometry (MS/MS) data without relying on sequence databases and is valuable for analyzing proteins from unknown species. However, existing Transformer-based approaches may not fully exploit interactions among precursor information, spectral features, and sequence prediction tokens, potentially limiting sequencing performance. We developed EncNovo, a nonautoregressive de novo peptide sequencing model based on a BERT-inspired encoder-only Transformer architecture. Precursor attributes, spectral peaks, and sequence prediction tokens are jointly encoded within a unified encoder, enabling continuous interaction among the three throughout the encoding process. A residual attention mechanism and a peak mass-difference inductive bias were further incorporated into the self-attention framework to encode amino acid residue mass relationships between spectral peaks. Experimental results on the nine-species benchmark dataset demonstrate that EncNovo improves peptide recall at 100% coverage by 5.10 and 4.18 percentage points on average compared with Casanovo and RefineNovo, respectively. The model also achieved higher amino acid recall and demonstrated faster convergence during training. Experimental results demonstrate that the proposed encoder-only framework, combined with residual attention and a peak mass-difference inductive bias, effectively improves peptide recall and accelerates model convergence. Collectively, these advantages make EncNovo a reliable framework for de novo peptide sequencing in proteomics.

PMID 43040950
阅读全文 →
PubMedJournal of medical cases2026-11-17

Anterior Pelvic Herniation After Urethral Atresia: A Case Report and the Bladder Space-Occupying Hypothesis.

Li Hai Nan HN, Liu Xiao Bao XB, Shen Ji Hong JH

We report a case of long-standing acquired urethral atresia in an adult, accompanied by bilateral ureterovaginal fistulas, severe bladder atrophy, and an anterior pelvic hernia. We propose a hypothetical biomechanical explanation to elucidate the possible relationship among these abnormalities. We report a 71-year-old female patient who had undergone urethral tumor resection at another hospital 10 years earlier and had since experienced persistent vaginal urine leakage for more than 10 years; she presented this time with a progressively enlarging vaginal mass. The diagnosis was established based on physical examination, contrast-enhanced computed tomography (CT), and intraoperative exploration findings. Intraoperative exploration revealed complete urethral obliteration, bilateral ureterovaginal fistulae, a severely atrophic bladder remnant, and an anterior pelvic hernia containing small bowel that protruded through the vesicouterine fossa and clinically resembled a grade III cystocele. The patient underwent excision of the prolapsed vaginal mass and bilateral cutaneous ureterostomy. Based on the clinical course, imaging findings, and intraoperative observations, a three-stage biomechanical cascade hypothesis is proposed: urethral outlet obstruction may lead to elevated intravesical pressure, which in turn causes "pressure-induced perforation" at the ureterovesical junction. Direct urine diversion through the fistula results in bladder disuse atrophy. Loss of the bladder's space-occupying function leads to reopening of the vesicouterine pouch, which then expands into an anterior pelvic hernia under repeated intra-abdominal pressure. To our knowledge, acquired urethral atresia with bilateral ureterovaginal fistulas in adults has not been previously reported. Although this hypothesis still requires further clinical and finite element modeling studies for precise validation, the proposed "bladder space-occupying effect hypothesis" may provide, in the future, a theoretical framework for subsequent research on atypical pelvic organ prolapse after long-term bladder disuse.

PMID 43042420
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多estradiol